Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Non Operating Income: 2009-2024

Historic Non Operating Income for Capricor Therapeutics (CAPR) over the last 15 years, with Dec 2024 value amounting to $2.1 million.

  • Capricor Therapeutics' Non Operating Income rose 278.11% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 64.04%. This contributed to the annual value of $2.1 million for FY2024, which is 17.17% up from last year.
  • As of FY2024, Capricor Therapeutics' Non Operating Income stood at $2.1 million, which was up 17.17% from $1.8 million recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Non Operating Income registered a high of $2.1 million during FY2024, and its lowest value of $32,943 during FY2020.
  • Its 3-year average for Non Operating Income is $1.5 million, with a median of $1.8 million in 2023.
  • Per our database at Business Quant, Capricor Therapeutics' Non Operating Income slumped by 64.22% in 2020 and then soared by 2,680.32% in 2021.
  • Over the past 5 years, Capricor Therapeutics' Non Operating Income (Yearly) stood at $32,943 in 2020, then skyrocketed by 2,680.32% to $915,922 in 2021, then dropped by 25.99% to $677,851 in 2022, then surged by 164.12% to $1.8 million in 2023, then rose by 17.17% to $2.1 million in 2024.